Advertisement

Epidemiologic aspects of lipid abnormalities

      Abstract

      Existing cholesterol guidelines aimed at preventing cardiovascular disease emphasize the role of total cholesterol (TC) and low-density lipoprotein (LDL) cholesterol in lipid management decisions, with a subsidiary role for high-density lipoprotein (HDL) cholesterol in guiding treatment and little role for triglycerides. In this article, epidemiologic evidence is reviewed relating to the independent value of lipid factors in prediction of cardiovascular disease risk, including TC, LDL cholesterol, HDL cholesterol, very-low-density lipoprotein (VLDL) cholesterol and triglycerides, LDL particle size (“pattern B”), and the TC/HDL-cholesterol ratio. Several observations are highlighted. Triglycerides appear to be an independent risk factor in specific populations. Postprandial triglycerides may be superior to fasting triglycerides as a predictor of risk. LDL particle size does not have independent predictive value after adjustment for triglycerides. Particular emphasis is placed on the observation that the single most predictive lipid factor is the TC/HDL-cholesterol ratio, which implicitly incorporates information on both LDL and triglycerides in the numerator. This is the best predictor both of outcome and of treatment benefit, and its predictive value appears to be maintained into older age. It is concluded that increasing emphasis should be placed on the TC/HDL cholesterol ratio in epidemiologic analyses and in monitoring patients on therapy for dyslipidemia.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Stamler J
        Established major coronary risk factors.
        in: Marmot M Elliot P Coronary Heart Disease Epidemiology. Oxford University Press, New York1992: 35-66
        • Martin M.J
        • Hulley S.B
        • Browner W.S
        • et al.
        Serum cholesterol, blood pressure, and mortality.
        Lancet. 1986; 2: 933-936
        • Verschuren W.M.M
        • Jacobs D.R
        • Bloemberg B.P
        • et al.
        Serum total cholesterol and long-term coronary artery disease mortality in different cultures.
        JAMA. 1995; 274: 131-136
        • Shipley M.J
        • Pocock S.J
        • Marmot M.G
        Does plasma cholesterol concentration predict mortality from coronary artery disease in elderly people? 18 year follow up in Whitehall study.
        BMJ. 1991; 303: 89-92
        • Shekelle R.B
        • Shryock A.M
        • Paul O
        • et al.
        Diet, serum cholesterol, and death from coronary heart disease.
        N Engl J Med. 1981; 304: 65-70
        • Robertson T.L
        • Kato H
        • Rhoads G.G
        • et al.
        Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California.
        Am J Cardiol. 1977; 39: 239-243
        • Kato H
        • Tillotson J
        • Nichaman M.Z
        • et al.
        Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California.
        Am J Epidemiol. 1973; 97: 372-385
        • Robertson T.L
        • Kato H
        • Gordon T
        • et al.
        Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California.
        Am J Cardiol. 1977; 39: 244-249
        • Castelli W.P
        Cholesterol and lipids in the risk of coronary heart disease—the Framingham Heart Study.
        Can J Cardiol. 1988; 4: 5A-10A
        • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
        Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II).
        JAMA. 1993; 269: 3015-3023
        • MacMahon S
        • Peto R
        • Cutler J
        • et al.
        Blood pressure, stroke, and coronary heart disease.
        Lancet. 1990; 335: 765-774
        • Glick H
        • Kinosian B
        Evaluating the efficiency of cholesterol modification for coronary heart disease with decision analytic models.
        Drug Information J. 1995; 29: 1441-1457
        • Kinosian B
        • Glick H
        • Preiss L
        • Puder K.L
        Cholesterol and coronary heart disease.
        J Investig Med. 1995; 43: 443-450
        • Weverling-Rijnsburger A.W
        • Blauw G.J
        • Lagaay A.M
        • et al.
        Total cholesterol and risk of mortality in the oldest old.
        Lancet. 1997; 350: 1119-1123
        • Gordon T
        • Castelli W.P
        • Hjortland M.C
        • et al.
        High density lipoprotein as a protective factor against coronary heart disease.
        Am J Med. 1977; 62: 707-714
        • Jacobs D.R
        • Mebane I.L
        • Bangdiwala S.I
        • et al.
        High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women.
        Am J Epidemiol. 1990; 131: 32-47
        • Laws A
        • Marcus E.B
        • Grove J.S
        • Curb J.D
        Lipids and lipoproteins as risk factors for coronary heart disease in men with abnormal glucose tolerance.
        J Intern Med. 1993; 234: 471-478
        • Laakso M
        • Lehto S
        • Penttilä I
        • Pyörälä K
        Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes.
        Circulation. 1993; 88: 1421-1430
        • Krauss R.M
        Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk.
        Curr Opin Lipidol. 1994; 5: 339-349
        • Hodis H.N
        • Mack W.J
        • Dunn M
        • et al.
        Intermediate-density lipoproteins and progression of carotid arterial wall intima-media thickness.
        Circulation. 1997; 95: 2022-2026
        • Stampfer M.J
        • Sacks F.M
        • Salvini S
        • et al.
        A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.
        N Engl J Med. 1991; 325: 373-381
        • Barr D.P
        • Russ E.M
        • Eder H.A
        Protein-lipid relationships in human plasma.
        Am J Med. 1951; 11: 480-493
        • Gordon D.J
        • Probstfield J.L
        • Garrison R.J
        • et al.
        High-density lipoprotein cholesterol and cardiovascular disease.
        Circulation. 1989; 79: 8-15
        • Castelli W.P
        • Doyle J.T
        • Gordon T
        • et al.
        HDL cholesterol and other lipids in coronary heart disease.
        Circulation. 1977; 55: 767-772
        • Mackness M.I
        • Durrington P.N
        HDL, its enzymes and its potential to influence lipid peroxidation.
        Atherosclerosis. 1995; 115: 243-253
        • Calabresi L
        • Franceschini G
        • Sirtori C.R
        • et al.
        Inhibition of VCAM-1 expression in endothelial cells by reconstituted high density lipoproteins.
        Biochem Biophys Res Commun. 1997; 238: 61-65
        • Barter P.J
        Inhibition of endothelial cell adhesion molecule expression by high density lipoproteins.
        Clin Exp Pharmacol Physiol. 1997; 24: 286-287
        • Sugatani J
        • Miwa M
        • Komiyama Y
        • Ito S
        High-density lipoprotein inhibits the synthesis of platelet-activating factor in human vascular endothelial cells.
        J Lipid Mediat Cell Signal. 1996; 13: 73-88
        • Laakso M
        • Voutilainen E
        • Pyorala K
        • Sarlund H
        Association of low HDL and HDL2 cholesterol with coronary heart disease in noninsulin-dependent diabetics.
        Arteriosclerosis. 1985; 5: 653-658
        • Hamsten A
        • Walldius G
        • Szamosi A
        • et al.
        Relationship of angiographically defined coronary heart disease to serum lipoproteins and apolipoproteins in young survivors of myocardial infarction.
        Circulation. 1986; 73: 1097-1110
        • Franceschini G
        • Bondioli A
        • Granata D
        • et al.
        Reduced HDL2 levels in myocardial infarction patients without risk factors for atherosclerosis.
        Atherosclerosis. 1987; 68: 213-219
        • Salonen J.T
        • Salonen R
        • Seppänen K
        • et al.
        HDL, HDL2, and HDL3 subfractions, and the risk of acute myocardial infarction.
        Circulation. 1991; 84: 129-139
        • Criqui M.H
        • Heiss G
        • Cohn R
        • et al.
        Plasma triglyceride level and mortality from coronary heart disease.
        N Engl J Med. 1993; 328: 1220-1225
        • Reaven G.M
        Syndrome X.
        J Intern Med. 1994; 236: 13-22
        • Assmann G
        • Funke H
        HDL metabolism and atherosclerosis.
        J Cardiovasc Pharmacol. 1990; 16: S15-S20
        • Genest Jr, J
        • McNamara J.R
        • Ordovas J.M
        • et al.
        Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary heart disease.
        J Am Coll Cardiol. 1992; 19: 792-802
        • Gaziano J.M
        • Hennekens C.H
        • O’Donnell C.J
        • et al.
        Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction.
        Circulation. 1997; 96: 2520-2525
        • Krauss R.M
        • Burke D.J
        Identification of multiple subclasses of plasma low density lipoproteins in normal humans.
        J Lipid Res. 1982; 23: 97-104
        • Austin M.A
        • Breslow J.L
        • Hennekens C.H
        • et al.
        Low-density lipoprotein subclass patterns and risk of myocardial infarction.
        JAMA. 1988; 260: 1917-1921
        • Stampfer M.J
        • Krauss R.M
        • Ma J
        • et al.
        A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction.
        JAMA. 1996; 276: 882-888
        • Gardner C.D
        • Fortmann S.P
        • Krauss R.M
        Association of small low-density lipoprotein particles with the incidence of coronary heart disease in men and women.
        JAMA. 1996; 276: 875-881
        • Patsch J.R
        • Miesenböck G
        • Hopferwieser T
        • et al.
        Relation of triglyceride metabolism and coronary heart disease.
        Arterioscler Thromb. 1992; 12: 1336-1345
        • Nikkilä M
        • Solakivi T
        • Lehtimäki T
        • et al.
        Postprandial plasma lipoprotein changes in relation to apolipoprotein E phenotypes and low density lipoprotein size in men with and without coronary heart disease.
        Atherosclerosis. 1994; 106: 149-157
        • Ginsberg H.N
        • Jones J
        • Blaner W.S
        • et al.
        Association of postprandial triglyceride and retinyl palmitate responses with newly diagnosed exercise-induced myocardial ischemia in middle-aged men and women.
        Arterioscler Thromb Vasc Biol. 1995; 15: 1829-1838
        • Sharrett A.R
        • Chambless L.E
        • Heiss G
        • et al.
        Association of postprandial triglyceride and retinyl palmitate responses with asymptomatic carotid artery atherosclerosis in middle-aged men and women.
        Arterioscler Thromb Vasc Biol. 1995; 15: 2122-2129
        • McKeigue P.M
        • Miller G.J
        • Marmot M.G
        Coronary heart disease in south Asians overseas.
        J Clin Epidemiol. 1989; 42: 597-609
        • McKeigue P.M
        • Ferrie J.E
        • Pierpoint T
        • Marmot M.G
        Association of early-onset coronary heart disease in South Asian men with glucose intolerance and hyperinsulinemia.
        Circulation. 1993; 87: 152-161
        • Bhatnagar D
        • Anand I.S
        • Durrington P.N
        • et al.
        Coronary risk factors in people from the Indian subcontinent living in west London and their siblings in India.
        Lancet. 1995; 345: 405-409
        • Castelli W.P
        • Abbott R.D
        • McNamara P.M
        Summary estimates of cholesterol used to predict coronary heart disease.
        Circulation. 1983; 67: 730-734
        • Kinosian B
        • Glick H
        • Garland G
        Cholesterol and coronary heart disease.
        Ann Intern Med. 1994; 121: 641-647
        • ASCN/AIN Task Force on Trans Fatty Acids
        Position paper on trans fatty acids.
        Am J Clin Nutr. 1996; 63: 663-670
        • Willett W.C
        • Stampfer M.J
        • Manson J.E
        • et al.
        Intake of trans fatty acids and risk of coronary heart disease among women.
        Lancet. 1993; 341: 581-585
        • Hu F.B
        • Stampfer M.J
        • Manson J.E
        • et al.
        Dietary fat intake and the risk of coronary heart disease in women.
        N Engl J Med. 1997; 337: 1491-1499
        • Pietinen P
        • Ascherio A
        • Kohonen P
        • et al.
        Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men.
        Am J Epidemiol. 1997; 145: 876-887